Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Packaging Becomes Enabler for Biopharmaceuticals

May 2, 2014

Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

Drug developers are taking a wait-and-see approach to the use of cocrystals.
May 2, 2014

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Process Design Is Critical for Commercial Manufacture of HPAPIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
May 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Advances in Continuous Biopharmaceutical Manufacturing

Both upstream and downstream processes can benefit from continuous manufacturing advantages.
Apr 16, 2014

Both upstream and downstream processes can benefit from continuous manufacturing advantages.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Apr 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
Apr 2, 2014

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.
Apr 1, 2014

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.

Synthetic Biology Stirs Interest in Greener, More Efficient Processes

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Apr 1, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Mar 2, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here